Short answer
SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on October 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.11 (Exhibit EX-99.11). Supernus scheduled third-quarter 2026 results for October 29, 2026, after market close.
SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Supernus scheduled third-quarter 2026 results for October 29, 2026, after market close
- Management conference call and webcast set for 4:30 p.m. ET on October 29
- Investors should watch the release for operating performance and business updates, with details in Exhibit 99.1
Item EX-99.11 · Exhibit EX-99.11
- Third-quarter 2026 results scheduled after market close on October 29, 2026
- Management conference call at 4:30 p.m. ET, providing guidance and business updates
- Investor focus: prescription trends, Sage-acquired products, profitability, and pipeline progress
- Webcast replay available for 60 days, enabling post-release review of management commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings
Get the next SUPN 8-K as it lands
Follow SUPN for push alerts, or ask the research agent what this filing means.